Kimberly-Clark (KMB), near 52-week lows, offers a 5.2% yield, Q1 organic growth, and Kenvue merger synergies—see why it’s a ...

A massive warehouse of paper products was totally destroyed by fire. A video on social media shows fires inside a warehouse, ...

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the cheap NASDAQ stocks to buy right now. On April 28, Kimberly-Clark reported solid Q1 2026 results, delivering $4.2 billion in net sales, a 2.7% ...

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q1 2026 investor letter for its “Large Cap ...

Kimberly-Clark will buy Kenvue for $48.7 billion. A merged Kimberly-Clark-Kenvue could have $32 billion in annual sales and profits as high as $5.5 billion. At Kimberly-Clark's current $40 billion ...

Kimberly-Clark (NasdaqGS:KMB) announced an agreement to acquire Kenvue, expanding its reach in consumer health brands. The company is realigning its joint venture with Suzano, which includes plans to ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Kenvue shareholders will receive $3.50 per share in ...

CHICAGO -- Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own ...

Kimberly-Clark, the maker of household brands such as Huggies and Kleenex, will acquire Kenvue, the consumer health company behind Tylenol, in a cash-and-stock transaction valued at $48.7 billion. The ...